Moderna stock plunges 18% after cutting 2025 sales forecast by $1BJanuary 13, 2025 Moderna stock dropped 18% after the company slashed its 2025 revenue forecast by $1 billion, citing declining COVID vaccine demand, market competition, and other financial challenges.
